Literature DB >> 25862840

Effects of antioxidants and pro-oxidants on cytotoxicity of dihydroartemisinin to Molt-4 human leukemia cells.

Thomas Gerhardt1, Ross Jones1, Jungsoo Park1, Rui Lu1, Ho Wing Chan1, Qingxi Fang1, Narendra Singh2, Henry Lai1.   

Abstract

BACKGROUND: The objective of the present study was to investigate how oxidative status influences the effectiveness of cytotoxicity of artemisinin towards cancer cells. It is hypothesized that antioxidants would reduce, whereas pro-oxidants would enhance, cytotoxicity.
MATERIALS AND METHODS: Molt-4 human leukemia cells were incubated with vitamins C, E, D3, dexamethasone, or hydrogen peroxide alone or in combination with dihydroartemisinin (DHA). Concentrations of these compounds studied were similar to those achievable by oral administration. Viable cell counts were performed before (0 h) and at, 24 and 48 h after treatment.
RESULTS: Vitamin C, vitamin D3, dexamethasone, and H2O2 caused significant Molt-4 cell death. Vitamin E caused an increase in Molt-4 cell growth. Vitamin C and vitamin D3 significantly interacted with DHA at the 48-h time point and with H2O2 at both 24-h and 48-h time points.
CONCLUSION: Cellular oxidative status could alter the potency of artemisinin in killing cancer cells. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Artemisinin; Molt-4 cells; Trolox; dexamethasone; hydrogen peroxide; sodium ascorbate; vitamin D3

Mesh:

Substances:

Year:  2015        PMID: 25862840

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Dihydroartemisinin Inhibits the Proliferation, Colony Formation and Induces Ferroptosis of Lung Cancer Cells by Inhibiting PRIM2/SLC7A11 Axis.

Authors:  Bing Yuan; Feng Liao; Zhi-Zhou Shi; Yuan Ren; Xiao-Li Deng; Ting-Ting Yang; Deng-Yuan Li; Ru-Fang Li; Dan-Dan Pu; Yu-Jue Wang; Yan Tan; Zhen Yang; Yun-Hui Zhang
Journal:  Onco Targets Ther       Date:  2020-10-27       Impact factor: 4.147

Review 2.  Artemisinin-type drugs for the treatment of hematological malignancies.

Authors:  R I Mancuso; M A Foglio; S T Olalla Saad
Journal:  Cancer Chemother Pharmacol       Date:  2020-11-03       Impact factor: 3.333

Review 3.  Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals.

Authors:  Alessandra Bosutti; Fabrizio Zanconati; Gabriele Grassi; Barbara Dapas; Sabina Passamonti; Bruna Scaggiante
Journal:  Anticancer Agents Med Chem       Date:  2016       Impact factor: 2.505

4.  Synthetic antioxidants from a natural source can overtake the oncogenic stress management system and activate the stress‑sensitized death of KSHV‑infected cancer cells.

Authors:  Piyanki Das; Goutam Brahmachari; Koustav Chatterjee; Tathagata Choudhuri
Journal:  Int J Mol Med       Date:  2022-07-20       Impact factor: 5.314

Review 5.  Development of nanoscale drug delivery systems of dihydroartemisinin for cancer therapy: A review.

Authors:  Ka Hong Wong; Donglin Yang; Shanshan Chen; Chengwei He; Meiwan Chen
Journal:  Asian J Pharm Sci       Date:  2022-05-14       Impact factor: 9.273

6.  Artemether suppresses cell proliferation and induces apoptosis in diffuse large B cell lymphoma cells.

Authors:  Xinying Zhao; Xudong Guo; Wenqin Yue; Jianmin Wang; Jianmin Yang; Jie Chen
Journal:  Exp Ther Med       Date:  2017-08-29       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.